New Ray Medicine International Holding Limited (HKG:2908)

HKG:2908 Income Statement

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	93.95	50.15	89.77	335.38	133.21
Revenue Growth (YoY)	87.31%	-44.13%	-73.23%	151.76%	12.29%
Cost of Revenue	95.57	38.81	118.96	306.89	122.28
Gross Profit	-1.62	11.34	-29.18	28.49	10.93
Selling, General & Admin	30.6	28.7	39.61	30.92	27.95
Operating Expenses	36.31	32.76	44.23	35.57	55.82
Operating Income	-37.94	-21.42	-73.42	-7.08	-44.89
Interest Expense	-0.1	-0.03	-0.18	-0.28	-0.11
Interest & Investment Income	2.53	3.68	3.37	1.3	1.76
Earnings From Equity Investments	-	-	-	1.11	1.48
Currency Exchange Gain (Loss)	-0.67	-0.57	-10.63	4.25	8.92
Other Non Operating Income (Expenses)	0.05	-2.11	0.07	0.09	0.1
EBT Excluding Unusual Items	-36.13	-20.45	-80.79	-0.62	-32.73
Gain (Loss) on Sale of Investments	3.93	0.42	-	-2.99	-37.33
Gain (Loss) on Sale of Assets	0.14	0.48	0.38	-0.01	-0.01
Asset Writedown	-	-2.8	-	-	-
Other Unusual Items	-	-	0.12	-	0.16
Pretax Income	-32.06	-22.34	-80.29	-3.61	-69.9
Income Tax Expense	-1.05	-0.17	-2.34	-0.78	-0.17
Net Income	-31.01	-22.17	-77.95	-2.82	-69.73
Net Income to Common	-31.01	-22.17	-77.95	-2.82	-69.73
Shares Outstanding (Basic)	167	167	167	167	167
Shares Outstanding (Diluted)	167	167	167	167	167
EPS (Basic)	-0.19	-0.13	-0.47	-0.02	-0.42
EPS (Diluted)	-0.19	-0.13	-0.47	-0.02	-0.42
Free Cash Flow	-5.39	-45.45	-9.02	-58.45	-31.84
Free Cash Flow Per Share	-0.03	-0.27	-0.05	-0.35	-0.19
Gross Margin	-1.73%	22.61%	-32.51%	8.49%	8.21%
Operating Margin	-40.38%	-42.71%	-81.78%	-2.11%	-33.70%
Profit Margin	-33.01%	-44.20%	-86.83%	-0.84%	-52.34%
Free Cash Flow Margin	-5.73%	-90.62%	-10.04%	-17.43%	-23.90%
EBITDA	-36.23	-16.63	-68.46	-2.86	-40.76
EBITDA Margin	-38.57%	-33.15%	-76.27%	-0.85%	-30.59%
D&A For EBITDA	1.7	4.8	4.95	4.22	4.13
EBIT	-37.94	-21.42	-73.42	-7.08	-44.89
EBIT Margin	-40.38%	-42.71%	-81.78%	-2.11%	-33.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.